NCT00976339View on ClinicalTrials.gov

Study of Vitamin D for Premenopausal Women at High Risk for Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Breast Cancer
Interventions
DRUG

Cholecalciferol

"Cholecalciferol is a vitamin D3. Vitamin D is important for the absorption of calcium from the stomach and for the functioning of calcium in the body. Cholecalciferol is used to treat or prevent many conditions caused by a lack of vitamin D.~Cholecalciferol will be available in gel capsule form at 10,000 IU (0.25 mg cholecalciferol) each."

Trial Locations (1)

10032

Columbia University Medical Center Herbert Irving Cancer Center, New York

All Listed Sponsors
collaborator

Prevent Cancer Foundation

OTHER

lead

Katherine D. Crew

OTHER

NCT00976339 - Study of Vitamin D for Premenopausal Women at High Risk for Breast Cancer | Biotech Hunter | Biotech Hunter